AHRQ To CMS: Acupuncture For Fibromyalgia Has “Insufficient Evidence”
This article was originally published in The Gray Sheet
Executive Summary
Two randomized controlled clinical trials currently underway may shed light on whether a national non-coverage determination should be reversed for acupuncture to treat fibromyalgia, according to an 1AHRQ technology assessment
You may also be interested in...
Acupuncture Noncoverage Decisions Maintained By CMS Due To Poor Data
Further evidence on the effect of sham versus real acupuncture for relief of osteoarthritis pain headlines a long list of research issues that need to be addressed before CMS reverses its noncoverage policy for the alternative therapy
Acupuncture Noncoverage Decisions Maintained By CMS Due To Poor Data
Further evidence on the effect of sham versus real acupuncture for relief of osteoarthritis pain headlines a long list of research issues that need to be addressed before CMS reverses its noncoverage policy for the alternative therapy
Osteoarthritis Acupuncture Evidence “Insufficient” – AHRQ Tech Assessment
Two randomized, controlled studies are being conducted to help determine whether a true benefit for acupuncture to treat osteoarthritis exists compared with placebo, according to an 1AHRQ tech assessment